Por: Fox Business Business August 08, 2023
Graviton Biopharmaceuticals Holdings CEO Sam Waksal argues that there will be 'great growth' in the pharmaceutical industry. Drugmaker Eli Lilly raised its full year forecast after demand surged for its popular The Indianapolis-based company reported Tuesday that its revenue rose 28% during the second quarter as a result of volume-driven growth from Mounjaro and other drugs, and the $579 million from the sale of rights for Baqsimi. As... + full article
Los Angeles Times USA Business March 01, 2023
Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions. The moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000... + más
Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions | NBC News
Eli Lilly plans to slash some insulin prices, expand cost cap | Portland Press Herald
Orlando Sentinel USA Business March 01, 2023
Eli Lilly caps out-of-pocket costs for insulin effective immediately | Fox Business
Time USA Health March 01, 2023
Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions. The moves announced Wednesday promise critical relief to some who can face annual costs of more than $1,000 for insulin they need... + más
Eli Lilly To Lower Insulin Prices And Introduce A $35 Out-Of-Pocket Monthly Cap For Commercially Insured And Uninsured Diabetics | Forbes
NBC News USA Nation March 01, 2023
Eli Lilly will cap the out-of-pocket cost of its insulin at $35 a month, the drugmaker said Wednesday. The move, experts say, could prompt other insulin makers in the U.S. to follow suit. The change, which Eli Lilly said takes effect immediately, puts the drugmaker in line with... + más
Eli Lilly plans to slash some insulin prices, expand cost cap | Orlando Sentinel
New York Daily News USA Nation March 01, 2023
Drugmaker Eli Lilly said Wednesday it would slash prices on several insulin formulations by 70% and expand eligibility for a monthly price cap. The move came as federal pressure mounted on the pharmaceutical giant and was hailed as a major win by advocates for people with... + más
Portland Press Herald USA World March 01, 2023
Forbes USA Business December 15, 2022
Along the corridors of Indianapolis-based Eli Lilly, NBP may not have the brand swagger of Trulicity or Mounjaro, but as the drugmaker eyes a rich menu of growth opportunities, the sturdy acronym promises to be a powerful pain reliever. Or so Lilly CFO Anat Ashkenazi explains,... + más
Twitter was once a necessity for major brands. Under Elon Musk, it's now high risk. | CBS News
A fake tweet sparked panic at Eli Lilly and may have cost Twitter millions | Portland Press Herald
About iurex | Privacy Policy | Disclaimer |